G-Protein Coupled Receptors Key Players and their Developments
The global G-protein coupled receptors market size is calculated at US$ 3.86 in 2024, grew to US$ 4.06 billion in 2025, and is projected to reach around US$ 6.37 billion by 2034. The market is expanding at a CAGR of 5.14% between 2024 and 2034.
Top Companies in the G-Protein Coupled Receptors Market
- Thermo Fisher Scientific Inc.
- Eurofins Scientific
- QIAGEN
- WuXi AppTec
- Promega Corporation
- Abcam plc
- Merck KGaA
- PerkinElmer Inc.
- Enzo Biochem Inc.
- BD
Recent Developments in the G-Protein Coupled Receptors Market
- In December 2024, Nature published a thorough paper. A novel synthetic receptor created by Stanford researchers can process a wider variety of inputs and generate a wider range of outputs. This invention, known as "Programmable Antigen-gated G protein-coupled Engineered Receptors" (PAGER), is based on G protein-coupled receptors, which are a group of more than 800 proteins found in the human body that activate G-proteins, which are molecular switches inside cells that regulate a variety of essential processes.
- In February 2024, the biotech innovation business Cumulus Oncology is pleased to announce the launch of GIO Therapeutics AG, a Basel, Switzerland-based company. Pharmaceutical development focusing on G protein-coupled receptors (GPCR) is the area of expertise for this recently founded biotech business.
